Key result
Workplace social capital was not associated with adherence to antihypertensive medication among employees with chronic hypertension.
Why the study?
Does high workplace social capital improve adherence to antihypertensive medication in hypertensive employees?
Cohort (n=3,515)
Yes
Does high workplace social capital improve adherence to antihypertensive medication in hypertensive employees?
Workplace social capital does not appear to significantly influence adherence to antihypertensive medication among employees with chronic hypertension.
Answers are grounded in this paper and cite their sources.
No association in this cohort; leaves open social capital's role in adherence and requires prospective confirmation.
BACKGROUND: While hypertension is a common and treatable health problem, adherence to antihypertensive medication remains a challenge. This study examines the hypothesis that workplace social capital may influence adherence to antihypertensive medication among hypertensive employees. METHODOLOGY/PRINCIPAL FINDINGS: We linked survey responses to nationwide pharmacy records for a cohort of 3515 hypertensive employees (mean age 53.9 years, 76% women) who required continuous antihypertensive drug therapy (the Finnish Public Sector study). A standard scale was used to measure workplace social capital from co-workers' assessments and self-reports in 2000-2004. Non-adherence to antihypertensive medication was determined based on the number of days-not-treated at the year following the survey using comprehensive prescription records. Negative binomial regression models were conducted adjusting for socio-demographic characteristics, duration of hypertension, behaviour-related risk factors, and co-morbid conditions. The overall rate of days-not-treated was 20.7 per person-year (78% had no days-not-treated). Higher age, obesity, and presence of somatic co-morbidities were all associated with better adherence, but this was not the case for co-worker-assessed or self-reported workplace social capital. The rate of days-not-treated was 19.7 per person-year in the bottom fourth of co-worker-assessed workplace social capital, compared to 20.4 in the top fourth. The corresponding rate ratio from the fully-adjusted model was 0.95 (95% confidence interval (CI) 0.58-1.56). In a subgroup of 907 new users of antihypertensive medication this rate ratio was 0.98 (95% CI 0.42-2.29). CONCLUSIONS/SIGNIFICANCE: We found no consistent evidence to support the hypothesized effect of workplace social capital on adherence to drug therapy among employees with chronic hypertension.
No takes yet. Share an insight, caveat, or question.
Oksanen et al. (2011) conducted a cohort in Hypertension (n=3,515). Workplace social capital vs. High workplace social capital was evaluated on Rate of days-not-treated per person-year (RR 0.95, 95% CI 0.58-1.56). Workplace social capital was not associated with adherence to antihypertensive medication among employees with chronic hypertension.
Synapse has enriched 10 related papers. Consider them for comparative context: